RxDoctor Payments Data

Mary Worthen, MD

Otolaryngology · Philadelphia, PANPI 1619219482

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 83.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $8,623 and has fallen 94.3% since, to $489 in 2025. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,138in general payments, 2019–2025

Across 96 payments — averaging $157.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$13K
  • Intersect ENT, Inc.$1K
  • Acclarent, Inc$888
  • Medtronic$174
  • Integra Lifesciences Corporation$38
  • Optinose US, Inc.$33
  • plus $63 from 3 others

What the payments were for

  • Consulting fees$2,85019%
  • Travel & lodging$6,05840%
  • Food & beverage$6,23041%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,138 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$108,468
Medicare patients
199
Services billed
1,157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide18$3,080
Azelastine-FluticasoneAzelastine/Fluticasone32$2,720
Fluticasone Propionate136$2,672
Azelastine Hcl40$1,384
Ipratropium Bromide38$1,034
Omeprazole13$367
Famotidine17$335
Levofloxacin17$133
Doxycycline Hyclate14$126
Cephalexin16$105
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$73
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$57
Prednisone12$42

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →